HONOLULU — AARP Hawai‘i is asking kupuna 50 and older to fill out online questionnaires and share their experiences and thoughts about the COVID-19 vaccine process in Hawai‘i.
HONOLULU — AARP Hawai‘i is asking kupuna 50 and older to fill out online questionnaires and share their experiences and thoughts about the COVID-19 vaccine process in Hawai‘i.
“We know that there is intense interest and desire from kupuna to get vaccinated for their own safety and for the safety of their loved ones,” said Keali‘i Lopez, the AARP Hawai‘i state director.
“We have been hearing from individual AARP members, and this questionnaire is an attempt to gather more information which can help guide our advocacy efforts and help the state improve the process.”
The online questionnaire is available at action.aarp.org/hivaccinesurvey. The results are being gathered through Monday, March 8.
AARP Hawai‘i will analyze the results and share them with key stakeholders and decision-makers, and post the results on the AARP Hawai‘i website.
AARP Hawai‘i will also discuss the results during AARP’s COVID-19 Vaccine Telephone Town Hall on Wednesday, March 10, at noon. Go to aarp.org/nearyou for more information and to register for the free telephone forum with Lt. Gov. Josh Green and Ron Balajadia, the head of the state Department of Health Immunization Branch.
The questionnaires ask whether people have tried to schedule a COVID-19 vaccination appointment, have gotten vaccinated, and what people think about how the state is balancing vaccinating kupuna and essential workers.
Responses are being solicited through the news media, the AARP Hawai‘i Facebook page, and through an email to members and nonmembers who have responded to past AARP Hawai‘i advocacy emails.
The results of this questionnaire are not scientific. But they should provide a variety of anecdotal experiences and a general sense of how kupuna are feeling about the vaccine rollout. AARP hopes to send out the questionnaire again next month to see if opinions and experiences are changing as the vaccine rollout continues.